Live from the NIH registry
Studies recruiting near Myrtle Beach right now
Top 25 of 95 recruiting studies, sorted by proximity — each links to its official registry page
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Carolina Regional Cancer Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: SWOG Cancer Research Network
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Steba Biotech S.A.
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-sensitive Prostate Cancer
Phase 2
Interventional 150 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 218 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
B-cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 164 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 1
Interventional 1,394 participants sought
Exelixis Clinical Site #9 — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Exelixis
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Non-muscle-invasive Bladder Cancer, NMIBC
Phase 1
Interventional 55 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Aura Biosciences
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
Prostate Cancer
Phase 1, Phase 2
Interventional 300 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Ferring Pharmaceuticals
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Metastatic Prostate Cancer
Phase 1, Phase 2
Interventional 283 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Hypertriglyceridemia, Severe Hypertriglyceridemia
Phase 2
Interventional 72 participants sought
Ionis Investigative Site — Little River, South Carolina (19.2 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Phase 2
Interventional 45 participants sought
START Carolinas — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Candel Therapeutics, Inc.
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
Trial Management Associates — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Hoffmann-La Roche
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Prostate Adenocarcinoma
Phase 1
Interventional 45 participants sought
Atlantic Urology Specialists — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Alessa Therapeutics Inc.
The ArtixASCEND Study
Acute Lower Limb Arterial Occlusion
N/A
Interventional 250 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Inari Medical
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Phase 1, Phase 2
Interventional 181 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
AMR Clinical - Myrtle Beach — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Interventional 400 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Dendreon
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Phase 2, Phase 3
Interventional 443 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 10,450 participants sought
Walker Family Care — Little River, South Carolina (19.2 mi)
· Sponsor: Eli Lilly and Company
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 75 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Kyntra Bio
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Type 2 Diabetes Mellitus
Phase 3
Interventional 600 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
Pneumococcal Disease
Phase 3
Interventional 4,670 participants sought
TMA Headlands LLC (d/b/a Trial Management Associates) — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pfizer
A Study of GEN1106 in Participants With Solid Tumors
Solid Tumors, Urothelial Carcinoma
Phase 1
Interventional 103 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Genmab
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Metastatic Castration Resistant Prostate Cancer
Phase 3
Interventional 600 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: ORIC Pharmaceuticals